Yunfei Chen

19PUBLICATIONS
43CO-AUTHORS
Adolescent healthEconomic models and forecastingHaematologyAutoimmunityTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 16, 2026
Factor IX Padua AAV gene therapy in adolescents with hemophilia B: a phase 1 trial.

|Aug 18, 2026
External validation of the AAA+ survival model in a large Chinese cohort with essential thrombocythaemia.

|Jul 01, 2026
Clinical heterogeneity in congenital factor XII deficiency: Coexisting risk factors in thrombotic and bleeding events.

|Apr 29, 2026
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial.

|Mar 12, 2026
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity.

Wei Liu, Xiaolei Pei, Tenghui Yu

|Oct 21, 2025
Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial.

Yunfei Chen, Yanmei Xu, Jiawen Dai

Pageof 4

Frequent Collaborators

15 joint publications

Lei Zhang

12 joint publications

Feng Xue

10 joint publications

Rongfeng Fu

8 joint publications

Huan Dong